224 related articles for article (PubMed ID: 9784666)
1. Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron.
Goodnough LT; Marcus RE
Vox Sang; 1998; 75(2):128-33. PubMed ID: 9784666
[TBL] [Abstract][Full Text] [Related]
2. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
Goodnough LT; Verbrugge D; Marcus RE; Goldberg V
J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
[TBL] [Abstract][Full Text] [Related]
3. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow.
Goodnough LT; Price TH; Rudnick S
J Lab Clin Med; 1991 Sep; 118(3):289-96. PubMed ID: 1919301
[TBL] [Abstract][Full Text] [Related]
4. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
5. Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
Bovy C; Baudoux E; Salmon JP; Beguin Y
Transfusion; 2006 Sep; 46(9):1616-23. PubMed ID: 16965592
[TBL] [Abstract][Full Text] [Related]
6. The relationship of erythropoietin and iron metabolism to red blood cell production in humans.
Adamson JW
Semin Oncol; 1994 Apr; 21(2 Suppl 3):9-15. PubMed ID: 8202725
[TBL] [Abstract][Full Text] [Related]
7. [Erythropoietin].
Kubanek B; Rich I; Noé G
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():46-50. PubMed ID: 7531047
[TBL] [Abstract][Full Text] [Related]
8. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender.
Goodnough LT; Price TH; Parvin CA
J Lab Clin Med; 1995 Jul; 126(1):57-64. PubMed ID: 7602235
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin, iron metabolism, and red blood cell production.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
[TBL] [Abstract][Full Text] [Related]
10. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant human erythropoietin on autologous blood donation for heart surgery].
Szöcs M; Donauer E; Simon J; Gál G; Kovács G
Orv Hetil; 1995 Aug; 136(33):1777-81. PubMed ID: 7651714
[TBL] [Abstract][Full Text] [Related]
12. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
[TBL] [Abstract][Full Text] [Related]
13. Optimizing autologous blood donation by recombinant human erythropoietin (rhu-EPO) and interleukin 3 (IL-3).
Krieter H; Frey L; Segiet W; Brückner UB; Krumwieh D; Seiler FR; Messmer K
Behring Inst Mitt; 1991 Dec; (90):75-85. PubMed ID: 1801694
[TBL] [Abstract][Full Text] [Related]
14. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
Opasich C; Cazzola M; Scelsi L; De Feo S; Bosimini E; Lagioia R; Febo O; Ferrari R; Fucili A; Moratti R; Tramarin R; Tavazzi L
Eur Heart J; 2005 Nov; 26(21):2232-7. PubMed ID: 15987710
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of oral versus parenteral iron substitution in autologous blood donors].
Schindler E; Scholz S; Boldt J; Zickmann B; Knothe C; Dietrich G; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):236-41. PubMed ID: 7950288
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
17. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
Daschner M; Mehls O; Schaefer F
Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
[TBL] [Abstract][Full Text] [Related]
18. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study.
DeAngelo AJ; Bell DG; Quinn MW; Long DE; Ouellette DR
Crit Care; 2005 Jun; 9(3):R172-6. PubMed ID: 15987387
[TBL] [Abstract][Full Text] [Related]
20. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.
Goodnough LT; Rudnick S; Price TH; Ballas SK; Collins ML; Crowley JP; Kosmin M; Kruskall MS; Lenes BA; Menitove JE
N Engl J Med; 1989 Oct; 321(17):1163-8. PubMed ID: 2677725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
